Author Topic: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan  (Read 4 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8564
  • MS diagnosed 1980
  • Location: Pacific Northwest
From MS Focus (July 24, 2020)--"Higher severe COVID-19 risk for patients on Ocrevus, Rituxan." The article quotes Dr. Ben Thrower, well known in MS research, as saying that the risk of taking MS disease-modifying therapy (DMT) still outweighs the benefits, however.


https://msfocus.org/About-Us/MSF-News-Articles/2279
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
62 Views
Last post December 13, 2018, 09:02:08 pm
by agate
0 Replies
6 Views
Last post April 07, 2020, 12:07:42 pm
by agate
0 Replies
4 Views
Last post May 15, 2020, 12:36:31 pm
by agate
0 Replies
8 Views
Last post May 18, 2020, 04:38:30 pm
by agate
0 Replies
14 Views
Last post July 03, 2020, 08:25:40 am
by agate